Related Experiment Video
Updated: Apr 23, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.1K
Insurance in clinical research.
Ravindra B Ghooi1, Deepa Divekar1
1Sahyadri Clinical Research and Development Centre, Erandwane, Pune, Maharashtra, India.
Perspectives in Clinical Research
|October 3, 2014
Summary
Clinical trial insurance policies often have deficiencies, failing to cover all potential reimbursements or compensation for serious adverse events. Ethics committees must critically review these complex insurance documents before approving trial protocols.
Area of Science:
- Clinical trial management
- Biomedical research
- Insurance law
Background:
- Sponsors are responsible for managing serious adverse events (SAEs) and compensating participants for trial-related injuries or deaths.
- Ensuring adequate financial coverage for unforeseen events is crucial for participant protection and trial integrity.
Purpose of the Study:
- To evaluate the comprehensiveness of clinical trial insurance policies in covering all potential reimbursements and compensation.
- To identify deficiencies in existing insurance policies that may impact sponsor obligations.
Main Methods:
- A review of insurance policies for clinical trials submitted to Sahyadri Hospitals between January 2013 and December 2013.
- Analysis focused on policy period, limits of liability, deductibles, and any stipulated preconditions.
Main Results:
- All reviewed insurance policies exhibited deficiencies.
- No policy fully covered all potential compensation requirements.
- Certain policy preconditions were identified as potential barriers to compensation for participants.
Conclusions:
- Clinical trial insurance policies are complex and require thorough scrutiny.
- Ethics committees must critically examine insurance documents to ensure adequate participant protection.
- Proactive review of insurance policies is essential to mitigate financial risks for sponsors and participants.
Related Concept Videos
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
622
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
622
01:11Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
01:28Preclinical Development: Overview
4.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.7K
01:12Hazard Ratio
741
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
741
01:56Ethics in Research
23.7K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.7K